Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pollak

Showing results (301-310 of 326) with videos related to

Pageof 33
Sort By:
Nature Genetics|June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionJochen Reiser, Krishna R Polu, Clemens C Möller, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Transplantation Proceedings|August 1, 1996
Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Journal of the American Society of Nephrology : JASN|January 10, 2015
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B Kopp, Cheryl A Winkler, Xiongce Zhao, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Circulation Research|January 1, 2014
Increased burden of cardiovascular disease in carriers of APOL1 genetic variantsKaoru Ito, Alexander G Bick, Jason Flannick, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell linesLijun Ma, Gregory S Shelness, James A Snipes, et al.
Pageof 33

Showing results (301-310 of 326) with videos related to

Sort By:
Pageof 33
Nature Genetics|June 1, 2005
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal functionJochen Reiser, Krishna R Polu, Clemens C Möller, et al.
Transplantation|March 27, 1996
The pharmacokinetics of a microemulsion formulation of cyclosporine in primary renal allograft recipients. The Neoral Study GroupG Barone, C T Chang, M G Choc, et al.
Transplantation|March 15, 1997
Safety and tolerability of cyclosporine microemulsion versus cyclosporine: two-year data in primary renal allograft recipients: a report of the Neoral Study GroupM D Pescovitz, G Barone, M G Choc, et al.
Transplantation Proceedings|August 1, 1996
Safety and tolerability of Neoral vs Sandimmune: 1-year data in primary renal allograft recipients. Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Journal of the American Society of Nephrology : JASN|January 10, 2015
Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical TrialJeffrey B Kopp, Cheryl A Winkler, Xiongce Zhao, et al.
The New England Journal of Medicine|March 15, 2023
Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> VariantsOgo Egbuna, Brandon Zimmerman, George Manos, et al.
Transplantation|March 27, 1996
The safety and tolerability of cyclosporine emulsion versus cyclosporine in a randomized, double-blind comparison in primary renal allograft recipients. The Neoral Study GroupG Barone, C M Bunke, M G Choc, et al.
Science (New York, N.Y.)|July 22, 2010
Association of trypanolytic ApoL1 variants with kidney disease in African AmericansGiulio Genovese, David J Friedman, Michael D Ross, et al.
Circulation Research|January 1, 2014
Increased burden of cardiovascular disease in carriers of APOL1 genetic variantsKaoru Ito, Alexander G Bick, Jason Flannick, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2014
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell linesLijun Ma, Gregory S Shelness, James A Snipes, et al.
Pageof 33